Two San Diego Biotech Firms Reach Settlement Over Prenatal Test Patents
On Wednesday, San Diego-based biotech companies Illumina and Sequenom announced that they reached a settlement over a patent dispute. Under the agreement, the firms will combine their patents for noninvasive prenatal tests, which are used to identify abnormalities in fetuses using DNA in the mother's blood.
- "Illumina, Sequenom Settle Patent Dispute" (Fikes, U-T San Diego, 11/3).